Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. [electronic resource]
- Circulation. Cardiovascular quality and outcomes May 2010
- 303-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
1941-7705
10.1161/CIRCOUTCOMES.109.890707 doi
Acute Coronary Syndrome--complications Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors--therapeutic use Clopidogrel Delivery of Health Care, Integrated Female Humans Male Middle Aged Myocardial Infarction--epidemiology Patient Discharge Platelet Aggregation Inhibitors--therapeutic use Retrospective Studies Risk Factors Survival Analysis Ticlopidine--analogs & derivatives United States Withholding Treatment